Tirofiban
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00775 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 11 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | Glanzmann thrombasthenia | KG + DL |
| 3 | rheumatoid arthritis | KG + DL |
| 4 | trigeminal autonomic cephalalgia | KG + DL |
| 5 | headache disorder | KG + DL |
| 6 | pseudo-von Willebrand disease | KG + DL |
| 7 | congenital prothrombin deficiency | KG + DL |
| 8 | thromboangiitis obliterans | KG + DL |
| 9 | female breast carcinoma | KG + DL |
| 10 | cholecystolithiasis | KG + DL |
| 11 | brachydactyly-syndactyly syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.